Khan Fasihul, Toor Sameen, Abdulqawi Rayid, Adamali Huzaifa, Chalmers James D, Chaudhuri Nazia, Ghouri Nazim, Jenkins R Gisli, Murphy Anna, Rahman Najib, Rashid Rafaqat, Satia Imran, Siddiqui Salman, Waqar Salman
Dept of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK.
King Faisal Specialist Hospital and Research Centre & College of Medicine, AlFaisal University, Riyadh, Saudi Arabia.
ERJ Open Res. 2025 Sep 22;11(5). doi: 10.1183/23120541.01102-2024. eCollection 2025 Sep.
Ramadan, observed by nearly 2 billion Muslims worldwide, involves fasting from dawn to sunset, which can present challenges for individuals with chronic respiratory diseases due to altered medication regimens and oral intake restrictions. This study aimed to synthesise current evidence and develop consensus recommendations for managing asthma, COPD, interstitial lung disease (ILD) and bronchiectasis during Ramadan.
A comprehensive search of electronic databases including MEDLINE, Embase and Google Scholar was conducted following a pre-specified protocol (PROSPERO identifier number CRD42024532759) to identify studies on Ramadan fasting outcomes in individuals with chronic respiratory diseases. The findings informed consensus recommendations stratified by the risk of adverse outcomes using International Diabetes Federation and the Diabetes and Ramadan risk assessment criteria. An international expert group of medical and religious experts refined these guidelines, achieving consensus approval.
11 studies met the inclusion criteria, primarily addressing asthma and COPD, with no relevant studies on ILD or bronchiectasis. The studies indicated that fasting did not significantly impact hospitalisation rates or lung function tests in individuals with stable asthma and COPD. However, small sample sizes and methodological limitations restricted generalisability. 19 recommendations were developed to support patients considering fasting, emphasising pre-Ramadan consultations, individualised risk assessments, and adjustments to medication regimens.
This systematic review highlights the need for larger, well-designed studies to understand Ramadan fasting implications across chronic respiratory diseases. The developed recommendations provide a structured approach to assess fasting risks, ensuring informed and safe guidance during Ramadan. Future research should address identified gaps, supporting evidence-based guidelines that reconcile medical and religious considerations.
全世界近20亿穆斯林都要遵守斋月,期间从黎明到日落禁食,这可能给患有慢性呼吸道疾病的人带来挑战,因为药物治疗方案会改变,且对口服摄入有限制。本研究旨在综合当前证据,并就斋月期间哮喘、慢性阻塞性肺疾病(COPD)、间质性肺疾病(ILD)和支气管扩张症的管理制定共识性建议。
按照预先指定的方案(PROSPERO标识符编号CRD42024532759),对包括MEDLINE、Embase和谷歌学术在内的电子数据库进行全面检索,以识别关于慢性呼吸道疾病患者斋月禁食结果的研究。研究结果为使用国际糖尿病联盟和糖尿病与斋月风险评估标准按不良后果风险分层的共识性建议提供了依据。一个由医学和宗教专家组成的国际专家组对这些指南进行了完善,并获得了共识认可。
11项研究符合纳入标准,主要涉及哮喘和COPD,没有关于ILD或支气管扩张症的相关研究。研究表明,禁食对稳定期哮喘和COPD患者的住院率或肺功能测试没有显著影响。然而,样本量小和方法学上的局限性限制了研究结果的普遍性。制定了19条建议来支持考虑禁食的患者,强调斋月前的咨询、个体化风险评估以及药物治疗方案的调整。
本系统评价强调需要开展规模更大、设计良好的研究,以了解斋月禁食对各种慢性呼吸道疾病的影响。所制定的建议提供了一种结构化方法来评估禁食风险,确保在斋月期间提供明智且安全的指导。未来的研究应填补已发现的空白,支持兼顾医学和宗教考量的循证指南。